Table 2.
Compilation of selected literature reports on the involvement on the expression and functions of the lysyl oxidase isozymes LOX and LOXL2 in selected tumour entities of various origins.
| Tumour entity | isoform | reference |
|---|---|---|
| Breast cancer | LOX | [53] |
| LOXL2 | [50c, 54] | |
| Lung cancer | LOX | [55] |
| LOXL2 | [56] | |
| Colorectal carcinoma | LOX | [57] |
| LOXL2 | [58] | |
| Pancreatic carcinoma | LOX | [59] |
| LOXL2 | [59a, 60] | |
| Gastric cancer | LOX | [51b] |
| LOXL2 | [61] | |
| Prostate cancer | LOX | [62] |
| LOXL2 | [63] | |
| Glioma | LOX | [64] |
| LOXL2 | [65] | |
| Head /neck tumours (squamous cell type) | LOX | [66] |
| LOXL2 | [67] | |
| Hepatocellular carcinoma | LOX | [68] |
| LOXL2 | [69] | |
| Skin cancer (w/o melanoma) | LOX | [70] |
| LOXL2 | [56a] |